PATENT CLAIM ANALYSIS

Application Number: 16098262
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "255050"]

Abstract:
The present invention relates to novel 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

Claim (Index 14):
The pharmaceutical composition of  claim 10  wherein the one or more further active ingredients is selected from the group consisting of\n diuretic, \n angiotensin All antagonist, \n ACE inhibitor, \n beta-receptor blocker, \n mineralocorticoid receptor antagonist, \n organic nitrate, \n NO donor, \n activator, \n stimulator of the soluble guanylate cyclase, \n positive-inotropic agent, \n antiinflammatory agent, \n immunosuppressive agent, \n phosphate binder, and \n compound which modulate vitamin D metabolism.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.68571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16098255', '15581064', '15969222', '13819885', '16098202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8158542031838099
- 35 USC 102 Novelty (BERT): 0.5961697037178776
- Combined Prediction Score: 0.7938857532372166
- Mean Citation Score: 423.403306
- Max Citation Score: 520.59686
- Similarity Product: 445.3207706279589

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test